Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

Xiuxiu Yang1, Debolina Chatterjee1, Justin L Couetil2

  • 1Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, United States.

Frontiers in Genetics
|December 16, 2024
PubMed

Insights

Cholesterol metabolism genes, particularly ADCY5 and SLC2A1, can improve colon cancer risk prediction. These genes highlight the tumor microenvironment

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colon cancer (CC) is a leading cause of cancer mortality and morbidity.
  • Cholesterol metabolism is increasingly recognized for its role in cancer prognosis and treatment response.
  • Understanding the molecular underpinnings of CC progression is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of cholesterol metabolism pathways in colon cancer.
  • To identify key genes within these pathways that predict CC patient prognosis.
  • To evaluate the efficacy of advanced machine learning models in CC risk stratification.

Main Methods:

  • Differential gene expression and KEGG pathway analysis on TCGA Colon Adenocarcinoma data.
  • Prognostic modeling using Cox proportional Hazard (CPH), Random Forest (RF), Lasso Regression (LR), and eXtreme Gradient Boosting (XGBoost).
  • Spatial transcriptomics (ST) and immunohistochemistry to localize gene expression.

Main Results:

  • Bile secretion was identified as the only significantly downregulated KEGG pathway in CC.
  • ADCY5 and SLC2A1 emerged as key predictive genes across multiple statistical models.
  • XGBoost models incorporating cholesterol metabolism genes significantly improved CC patient risk stratification compared to traditional models.
  • Spatial analysis revealed SLC2A1 colocalized with blood vessels and ADCY5 with stromal regions, indicating expression outside the tumor itself.

Conclusions:

  • Cholesterol metabolism, specifically the bile secretion pathway, is altered in colon cancer.
  • ADCY5 and SLC2A1 are significant prognostic biomarkers for colon cancer.
  • Advanced machine learning models enhance risk prediction for CC patients.
  • The tumor microenvironment and its interaction with normal tissues, involving genes like ADCY5 and SLC2A1, represent potential therapeutic targets.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
501
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
369
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K